Moderna halts plans to build Kenya vaccine plant as Covid shot demand plunges

A nurse prepares a dose of Moderna Covid-19 vaccine at Oltepesi Dispensary in Kajiado, Kenya, on…

Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump

Nikos Pekiaridis | Lightrocket | Getty Images Moderna has more to offer beyond its Covid vaccine.…

Pfizer RSV vaccine maintains protection in older adults over two seasons in trial

Respiratory syncytial virus vial. Manjurul | Istock | Getty Images Pfizer‘s vaccine against respiratory syncytial virus…

Moderna posts surprise quarterly profit even as Covid vaccines sales plummet

Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Thursday posted a surprise quarterly profit, in…

GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost

Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. …

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium.  NYSE Big…

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

US Senator Bernie Sanders, Independent of Vermont, speaks during a rally by the People’s Action, protesting…

Moderna Covid vaccine sales plunge by two-thirds in 2023, but meet company’s $6 billion forecast

Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Monday said its Covid vaccine sales plunged…

Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years

Artur Widak | Nurphoto | Getty Images Shares of Moderna jumped more than 15% on Tuesday…

Here are the big health sector themes to watch next year

An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May…